NewsBenzingaLucid Diagnostics Receiving Medicare Payments For Its EsoGuard Esophageal DNA Test; Closed $15M Private Placement Of Its Newly Designated Series C Convertible Prefs To Existing Long-Term Shareholders On October 21 Lucid Diagnostics Receiving Medicare Payments For Its EsoGuard Esophageal DNA Test; Closed $15M Private Placement Of Its Newly Designated Series C Convertible Prefs To Existing Long-Term Shareholders On October 21 Benzinga 2026.10.22 20:28 (GMT+0) Open on Benzinga Other news What to Expect From Extra Space Storage's Q3 2026 Earnings Report Verizon Stock Sinks After Hours as SpaceX Eyes 80,000 US Cell Sites for Fourth Wireless Carrier Push Cobalt Miners News For The Month Of October 2026 UAE Teams Up with 30 Countries and Multiple Companies to Target Cross-Border Digital Scam Networks, Identifying Over $39 Billion in Crypto and Fiat Bar Harbor Stock: A Great Quarter Bucking The Trend (NYSE:BHB) Trump Says Elon Musk Restored Ukraine’s Starlink Access, But Kyiv Says Speeds Remain Restricted
UAE Teams Up with 30 Countries and Multiple Companies to Target Cross-Border Digital Scam Networks, Identifying Over $39 Billion in Crypto and Fiat
